Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
about
Extent of lymph node dissection for adenocarcinoma of the stomachOn the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancerGastric cancer: Current status of lymph node dissectionClinical significance of lymphadenectomy in patients with gastric cancerAdvanced gastric cancer: What we know and what we still have to learnTowards curative therapy in gastric cancer: Faraway, so close!The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer.Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.Adjuvant therapy for gastric cancer: current and future directions.Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis."Fast track" rehabilitation after gastric cancer resection: experience with 80 consecutive cases.A meta-analysis of D1 versus D2 lymph node dissection.Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer.Surgical management of gastric cancer: the East vs. West perspectiveNomogram Estimating the Probability of Intraabdominal Abscesses after Gastrectomy in Patients with Gastric Cancer.Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial.Advances in the treatment of patients with gastric adenocarcinoma.How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience.Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials.Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.Clinical significance of lymph node metastasis in gastric cancer.A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer.Surgical approaches to gastric cancer.Quality of care indicators for the surgical treatment of gastric cancer: a systematic review.Lymph node dissection for gastric cancer: a critical review.Lymph node dissection in curative gastrectomy for advanced gastric cancer.Evaluation the Survival of Patients with Gastric Cancer Treated with Adjuvant or Palliative Chemotherapy.Multivariate logistic regression analysis of postoperative complications and risk model establishment of gastrectomy for gastric cancer: A single-center cohort report.Overall Survival Is Impacted by Birthplace and Not Extent of Surgery in Asian Americans with Resectable Gastric Cancer.R0 resection in the treatment of gastric cancer: room for improvement.Postoperative pancreatic fistula formation according to ISGPF criteria after D2 gastrectomy in Western patients.Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis.Personalized Surgery for Gastric Adenocarcinoma: A Meta-analysis of D1 versus D2 Lymphadenectomy.Race and correlations between lymph node number and survival for patients with gastric cancer.Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system.Race and ethnicity correlate with survival in patients with gastric adenocarcinoma.Gastric Cancer Surgery: East and West.Favoring D2-Lymphadenectomy in Gastric Cancer.
P2860
Q24187911-8AE3B504-0235-4995-B609-D6C72AB00C47Q26744183-A21E92F2-EAF6-4867-B96C-A6E049CEEE03Q26766091-C78C45DC-83B6-4000-9DB2-3C3B691D74C1Q26766698-6188D32D-9FF3-4BF1-823F-7F5C86835C53Q26774528-C8CD4418-CDD5-4D05-964A-7FE5FAA92847Q26778029-900AB27E-A84D-4959-B727-EBC2A1146DFCQ33608236-F05137E7-3A80-49D9-9E36-3A4022650138Q34255463-7B533CB9-AE22-476B-A8AC-7A08083230C4Q34326579-AD3EA82D-50ED-4CE8-87B0-E79F7069F0FEQ34405857-7F0F5FCA-2D9B-4259-90C7-BF3810F272DFQ34538055-80413D27-794A-4919-A554-39AE41C7E97AQ34634079-4DB734F9-41B7-439E-9B6C-E985622C51ECQ34660654-39402CD5-8CF4-406A-A806-4AABF8F6E6F0Q34962070-89C694A5-76B8-4426-8544-8F96EFEB9206Q36491325-13A74ABE-C86D-4891-A272-34F2741D4872Q36500558-A5AA342C-4277-4D53-A438-98D0CAC25D5DQ36608800-B21D5196-30A3-4B9D-B25F-862B7920686BQ36798382-9AFF2172-DC4D-462C-A14E-F0D073110ABFQ37035123-7FD5F08F-8340-45C2-B7E6-E0413A62B24FQ37333838-3DF1A3D3-76BC-4093-896D-6977CA6157ADQ37697546-70A69DD1-B463-43F9-8E73-CBDAABB81E72Q37697557-EF748AF8-1984-4F06-9973-B3B799D8CBF5Q37931733-340285EB-00D9-4275-86FD-1FD6BA677D07Q38016802-6515B527-4D02-48B7-BFC1-3CA66ADF67D8Q38051100-18FCBFD5-A592-4CF1-A190-2F60DFE86C03Q38493106-2F7B1E3F-298A-47D3-80D5-ECCCB1A5DCB6Q40584507-8239DC8A-E306-4CDD-A8F7-557444ADD1E0Q40614622-E95AFCEB-C45B-4FA9-9A49-9A1C9C671684Q40675084-48D6EB80-4399-49F0-A417-86A0EBCEDDA2Q41452357-719B84F0-CE69-4443-966D-686856946797Q42732352-6E6974FF-735F-4D6C-B022-0BD95A0FB35DQ43461521-DD04FBB1-466D-44A9-AEF0-0DD7A6197CD1Q43815683-18D3F10E-1C76-4907-95BF-F0848FC8DB02Q44286706-253619DE-2642-496C-9C03-CE93A2215863Q44551895-0D30F530-FC1C-4D09-A6A5-8A7AECD69083Q46106512-96783654-62E1-4F49-9943-0236635AC5AEQ47428511-15AD73C4-AA43-4D00-8BFD-C9A92AF8F653Q47633003-612D5AA8-55BD-473D-9462-AFAB2A5D9BF0Q50416851-6D49D52F-C666-4CAC-938A-9B1DD626A263Q55357371-F423B96B-E1FC-4DA1-ADB3-FA85C5362812
P2860
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@en
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@nl
type
label
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@en
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@nl
prefLabel
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@en
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@nl
P2093
P356
P1476
Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.
@en
P2093
P304
P356
10.1002/BJS.4433
P407
P577
2004-03-01T00:00:00Z